Oncology Institute Inc (TOI) — Capital Reinvestment Ratio
Oncology Institute Inc (TOI) has a Capital Reinvestment Ratio of 0.33x as of December 2025, meaning it reinvests 0% of its operating cash flow ($3.23 Million) in capital expenditures ($1.06 Million). Check tangible net worth ratio of Oncology Institute Inc to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Oncology Institute Inc Capital Reinvestment Ratio (2018–2020)
This chart tracks Oncology Institute Inc's Capital Reinvestment Ratio across 3 annual periods. For the full cash flow conversion analysis, see Oncology Institute Inc (TOI) cash conversion ratio.
Annual Capital Reinvestment Ratio for Oncology Institute Inc (2018–2020)
Year-by-year Capital Reinvestment Ratio for Oncology Institute Inc from 2018 to 2020. See TOI free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 2.35x | $508.00K | $1.19 Million | ▲ +605.4% |
| 2019 | 0.33x | $3.62 Million | $1.20 Million | ▲ +170.1% |
| 2018 | 0.12x | $5.64 Million | $695.96K | — |